Key Takeaway
Not everyone wants to inject. For some applications, especially neurological ones, a BPC-157 nasal spray may be the preferred delivery method. Intranasal delivery bypasses the GI system and provides more direct access to the central nervous system through the nasal mucosa and olfactory pathway.
Not everyone wants to inject. For some applications, especially neurological ones, a BPC-157 nasal spray may be the preferred delivery method. Intranasal delivery bypasses the GI system and provides more direct access to the central nervous system through the nasal mucosa and olfactory pathway.
Key Takeaways: - Discover why nasal delivery for bpc-157 - Learn how to prepare a bpc-157 nasal spray - Dosing BPC-157 Nasal Spray - Neurological Applications of BPC-157 Nasal Spray - Storage and Shelf Life for Nasal BPC-157
This guide covers how to prepare a BPC-157 nasal spray from reconstituted peptide, how to adjust dosing for nasal delivery, and what the research says about neurological applications. As always, this should be done under the guidance of a licensed provider who can prescribe and monitor your protocol.
Why Nasal Delivery for BPC-157?
Nasal spray delivery offers specific advantages over subcutaneous injection for certain use cases.
Blood-brain barrier access. The nasal cavity has a unique connection to the brain through the olfactory nerve and trigeminal nerve pathways. Intranasal administration can deliver peptides more directly to the central nervous system than subcutaneous injection. This makes nasal delivery especially interesting for neurological applications of BPC-157.
Non-invasive administration. Some people are uncomfortable with needles or deal with needle phobia that makes daily injections impractical. Nasal spray offers a pain-free alternative that doesn't require injection technique or sterile preparation at each dose.
Systemic absorption. The nasal mucosa has rich blood supply. Peptides absorbed through nasal tissue enter the bloodstream quickly, similar to sublingual absorption. This provides decent systemic bioavailability without passing through the digestive system where oral BPC-157 would face degradation.
Convenience. A prepared nasal spray can be used anywhere without the need for alcohol swabs, syringes, or privacy for injection. For people with busy schedules or who travel frequently, this convenience matters.
But nasal delivery isn't ideal for all BPC-157 applications. For localized injury healing (tendon, muscle, joint), subcutaneous injection near the injury site is still the preferred method. Nasal delivery excels when the target is the brain or when systemic distribution is the goal.
For a full overview of BPC-157, see our .
Free Download: BPC-157 Reconstitution calculator Cheat Sheet Includes reconstitution ratios for both injection and nasal spray preparation, dosing calculators, and storage guidelines for all delivery methods. Get yours free) we'll email it to you instantly. [Download Now]
"The conversation about obesity needs to shift from willpower to biology. These medications work because obesity is a neuroendocrine disease, not a character flaw.", Dr. Fatima Cody Stanford, MD, MPH, Massachusetts General Hospital
How to Prepare a BPC-157 Nasal Spray
Preparing a BPC-157 nasal spray involves reconstituting the lyophilized peptide and transferring it to an appropriate nasal spray device. Here are the steps your provider may guide you through.
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
What you need:
- BPC-157 lyophilized powder (prescribed by your provider, from a licensed 503A pharmacy)
- Bacteriostatic water or sterile saline for reconstitution
- A nasal spray bottle (metered-dose nasal spray bottles deliver approximately 0.1 mL per spray)
- Alcohol swabs
- Insulin syringe for measuring and transferring
Step 1[1]: Calculate your reconstitution volume. The volume of bacteriostatic water you add determines the concentration per spray. With a standard metered-dose nasal bottle delivering 0.1 mL per spray, you need to work backward from your target dose per spray.
Patient Perspective: "I tried BPC-157 for a chronic rotator cuff issue after 8 months of physical therapy with minimal improvement. Within 3 weeks of a BPC-157 protocol alongside continued PT, I noticed significantly less pain during overhead movements. I can't say for certain what caused the improvement, but the timeline was notable.", Chris D., 38, FormBlends patient (name changed for privacy)
For example, if you have a 5 mg (5000 mcg) vial and want approximately 250 mcg per spray: - 5000 mcg divided by 250 mcg = 20 sprays - 20 sprays times 0.1 mL = 2 mL total reconstitution volume
Use the to get exact numbers for your specific vial size and target dose.
Step 2: Reconstitute the peptide. Clean the vial stopper with an alcohol swab. Slowly add bacteriostatic water to the vial by directing the stream against the glass wall, not directly onto the powder. Let it dissolve naturally. Don't shake. Gentle swirling is acceptable if needed.
Step 3: Transfer to the nasal spray bottle. Using an insulin syringe, draw the reconstituted solution from the vial and carefully transfer it into a clean nasal spray bottle. Some providers supply pre-filled nasal spray devices, which eliminates this step.
Step 4: Prime the spray bottle. Before your first use, pump the spray bottle several times until a fine mist appears. This ensures consistent dosing from the first actual dose onward.
Important note: Your provider should guide you through this process or provide a pre-made nasal spray. The steps above are educational. Reconstitution and preparation should follow your provider's specific instructions.
Dosing BPC-157 Nasal Spray
Nasal spray dosing differs from subcutaneous injection dosing. Here's what to know.
From the FormBlends catalog
BPC-157
The body protection compound for accelerated healing · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View BPC-157 →Typical nasal dose range. Providers generally recommend 200 to 400 mcg per dose intranasally, administered 1 to 2 times daily. This is similar to subcutaneous dosing ranges, though bioavailability through the nasal route may differ.
Bioavailability considerations. Not all of the peptide sprayed into the nose will be absorbed. Some gets swallowed, some doesn't fully penetrate the nasal mucosa. Providers may adjust doses slightly higher than subcutaneous doses to account for this difference. But the direct nose-to-brain pathway may compensate for lower systemic bioavailability when the CNS is the target.
Administration technique matters. For best absorption:
- Clear your nose gently before dosing.
- Tilt your head slightly forward, not backward.
- Insert the spray tip just inside the nostril.
- Aim toward the outer wall of the nasal cavity, not straight up.
- Spray while gently inhaling through the nose.
- Alternate nostrils between doses.
- Avoid blowing your nose for at least 10 minutes after administration.
Cycle length. Nasal BPC-157 cycles follow the same general 4-to-6-week framework as injectable protocols. Learn more about and rest periods between cycles.
Track your nasal doses with the to maintain consistent protocol adherence and share data with your provider.
Neurological Applications of BPC-157 Nasal Spray
The primary reason for nasal BPC-157 delivery is to target the central nervous system. Here's what the research suggests.
Traumatic brain injury (TBI). Animal studies have shown BPC-157 may have neuroprotective effects following traumatic brain injury. Treated animals showed reduced brain edema, improved behavioral outcomes, and decreased neuroinflammation compared to controls. Nasal delivery is considered the most practical route for CNS-targeted peptide therapy.
Peripheral nerve damage. BPC-157 has demonstrated nerve regeneration properties in animal models of crushed and transected nerves. While subcutaneous injection near the nerve injury site may also be effective, nasal delivery provides systemic and CNS-level support that could complement local treatment.
Cognitive function. Some animal studies have explored BPC-157's effects on memory, learning, and dopaminergic pathways. Researchers have observed improvements in dopamine system function in BPC-157-treated animals, which is relevant for cognitive performance and mood regulation.
Important context. All of these findings come from animal research. There are no large-scale human clinical trials confirming these neurological benefits. The research is promising enough that some providers consider it clinically relevant, but claims should be tempered by the current evidence level.
For athletes dealing with concussion history or repetitive head impacts, nasal BPC-157 is an area of growing interest. Our guide on covers other athletic applications.
Storage and Shelf Life for Nasal BPC-157
Once prepared, your nasal spray needs the same careful storage as injectable BPC-157.
Refrigerate at 2 to 8 degrees Celsius. Keep the nasal spray bottle in the fridge between uses. Don't leave it in a bathroom medicine cabinet, car, or anywhere that experiences temperature fluctuations.
Use within 28 days. The same 28-day window applies to reconstituted nasal spray as to injectable solutions. Mark the preparation date on the bottle. Our detailed guide on covers everything you need to know about shelf life.
Protect from light. Store in the original box or wrap in aluminum foil if the spray bottle is clear.
Keep the nozzle clean. Wipe the spray tip with a clean tissue after each use. Don't share nasal spray bottles with anyone else.
Watch for signs of degradation. If the solution becomes cloudy, develops particles, or changes color, discard it and prepare a fresh batch.
Frequently Asked Questions
Is nasal BPC-157 as effective as injectable?
It depends on the goal. For local tissue repair (tendons, muscles, joints), subcutaneous injection near the injury site is generally considered more effective because it delivers a higher local concentration. For neurological applications or systemic effects, nasal delivery may be preferable due to the nose-to-brain pathway. Discuss your specific goals with your provider.
Can I buy a pre-made BPC-157 nasal spray?
Some compounding pharmacies prepare pre-filled BPC-157 nasal spray devices when prescribed by a provider. This eliminates the need to prepare your own. Ask your FormBlends provider about availability. Pre-made sprays offer the advantage of precise dosing and professional preparation.
How many sprays per day should I take?
Most protocols call for 1 to 2 sprays per nostril, 1 to 2 times daily, depending on the dose per spray and your provider's recommendation. This typically delivers 200 to 400 mcg per administration. Your provider will set the exact protocol based on your needs.
Does BPC-157 nasal spray have a taste or smell?
Most people report little to no taste or smell from BPC-157 nasal spray when prepared with bacteriostatic water or sterile saline. Some people notice a slight saline taste in the back of the throat after administration. This is normal and indicates the spray is reaching the nasopharyngeal area.
Can I use nasal BPC-157 for gut healing instead of injection?
Nasal delivery isn't the optimal route for gut healing applications. For gastrointestinal issues, oral BPC-157 capsules or subcutaneous injection may be more appropriate. The nasal route is best suited for neurological targets and systemic distribution. Discuss the best delivery method for your specific condition with your provider.
Start your progress Today
Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you, consultations are free and confidential.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
- Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity (STEP 4). JAMA. 2021;325(14):1414-1425. [PubMed | ClinicalTrials.gov | DOI]
Sources &. References
- Sikiric P, Hahm KB, Blagaic AB, et al. Stable Gastric Pentadecapeptide BPC 157, Robert's Cytoprotection, Adaptive Cytoprotection, and Therapeutic Effects. Curr Pharm Des. 2018;24(18):1990-2001. Doi:10.2174/1381612824666180515125918
- Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780. Doi:10.1152/japplphysiol.00945.2010
- Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-1125. Doi:10.2174/13816128113199990421
This content is provided for informational and educational purposes only. It isn't a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed healthcare provider with any questions about a medical condition or treatment plan.
Last updated: 2026-03-24
Ready when you are
BPC-157
The body protection compound for accelerated healing · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View BPC-157 →